The purpose of this expanded access program (EAP) is to provide ciltacabtagene autoleucel (cilta-cel) that does not meet the commercial release specifications of CARVYKTI and is not available via the local health care system in the country where the…
- Investigator
- Muhammad J Tariq
- Status
- Accepting Candidates
- Ages
- Adults
- Sexes
- All